CHLOROQUINE
CAS No. 54-05-7
CHLOROQUINE ( —— )
产品货号. M22541 CAS No. 54-05-7
Chloroquine 是一种自噬和 Toll 样受体 (TLR) 抑制剂。氯喹是一种抗疟和抗炎药,广泛用于治疗疟疾和类风湿性关节炎。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥138 | 有现货 |
|
| 25MG | ¥197 | 有现货 |
|
| 50MG | ¥272 | 有现货 |
|
| 100MG | ¥374 | 有现货 |
|
| 500MG | ¥1314 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥198 | 有现货 |
|
生物学信息
-
产品名称CHLOROQUINE
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Chloroquine 是一种自噬和 Toll 样受体 (TLR) 抑制剂。氯喹是一种抗疟和抗炎药,广泛用于治疗疟疾和类风湿性关节炎。
-
产品描述Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro with EC50 of 1.13 μM.Chloroquine suppressed matrix metalloproteinase (MMP)-2 and MMP-9 mRNA expression and protein activity, whereas MMP-13 mRNA expression and proteolytic activity were increased.?Despite enhancing TLR9 mRNA expression, chloroquine suppressed TLR9 protein expression in vitro.Daily treatment of mice with intraperitoneal (i.p.) chloroquine (80 mg/kg/day) for 22 days, did not inhibit the growth of control siRNA or TLR9 siRNA MDA-MB-231 breast cancer cells.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Microbiology/Virology
-
靶点HIV
-
受体HIV-1|autophagy|TLR|SARS-COV-2
-
研究领域——
-
适应症——
化学信息
-
CAS Number54-05-7
-
分子量319.87
-
分子式C18H26ClN3
-
纯度>98% (HPLC)
-
溶解度DMSO:100 mg/mL (312.63 mM); Ethanol:100 mg/mL (312.63 mM; Need ultrasonic)
-
SMILESCCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Tuomela J, et al. Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer. Oncol Lett. 2013 Dec;6(6):1665-1672.
产品手册
关联产品
-
BMS-818251
BMS-818251 (BMS818251) 是一种新型有效的 HIV-1 进入小分子抑制剂,针对实验室适应的 HIV-1 菌株 NL4-3 的 EC50 为 0.019 nM。
-
Enfuvirtide
Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection.
-
14-Dicaffeoylquinic ...
1,4-二咖啡酰奎尼酸具有抗氧化活性。1,4-二咖啡酰奎尼酸是一类有效且高度选择性的 HIV-1 整合酶抑制剂,可在无毒浓度下抑制 MT-2 细胞培养物中的 HIV-1 复制。
021-51111890
购物车()
sales@molnova.cn

